Casdin Capital’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,000,000
| Closed | -$13.9M | – | 41 |
|
|
2022
Q1 | $13.9M | Hold |
1,000,000
| – | – | 0.62% | 30 |
|
|
2021
Q4 | $28.1M | Sell |
1,000,000
-440,000
| -31% | -$12.3M | 0.79% | 31 |
|
|
2021
Q3 | $48.9M | Hold |
1,440,000
| – | – | 1.22% | 29 |
|
|
2021
Q2 | $58.8M | Buy |
1,440,000
+290,000
| +25% | +$11.8M | 1.49% | 21 |
|
|
2021
Q1 | $46.3M | Buy |
1,150,000
+436,875
| +61% | +$17.6M | 1.38% | 18 |
|
|
2020
Q4 | $42.2M | Hold |
713,125
| – | – | 1.25% | 20 |
|
|
2020
Q3 | $34.7M | Hold |
713,125
| – | – | 1.55% | 21 |
|
|
2020
Q2 | $34.5M | Sell |
713,125
-80,000
| -10% | -$3.87M | 2.04% | 16 |
|
|
2020
Q1 | $22M | Buy |
793,125
+330,000
| +71% | +$9.17M | 2.34% | 17 |
|
|
2019
Q4 | $13.9M | Hold |
463,125
| – | – | 1.27% | 25 |
|
|
2019
Q3 | $14.3M | Hold |
463,125
| – | – | 1.48% | 22 |
|
|
2019
Q2 | $20.1M | Buy |
+463,125
| New | +$20.1M | 1.88% | 18 |
|